Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Brand new drug composition containing levamlodipine besylate and candesartan cilexetil and preparation method thereof

A technology of levamlodipine besylate and candesartan cilexetil, applied in the field of new pharmaceutical composition containing levamlodipine and candesartan cilexetil and its preparation

Active Publication Date: 2013-05-01
HAINAN JINRUI PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] For overcoming above-mentioned defect, the inventor starts with levamlodipine besylate which is insoluble in water, and has made a kind of levamlodipine besylate crystal through a large amount of refining tests, and this crystal can improve benzene to a certain extent. The solubility of levamlodipine sulfonate, and it is more surprising to find that the pharmaceutical composition adopting the crystal and candesartan cilexetil can well overcome the above-mentioned defects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Brand new drug composition containing levamlodipine besylate and candesartan cilexetil and preparation method thereof
  • Brand new drug composition containing levamlodipine besylate and candesartan cilexetil and preparation method thereof
  • Brand new drug composition containing levamlodipine besylate and candesartan cilexetil and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] [embodiment 1] preparation of levamlodipine besylate crystal

[0075] 1) levamlodipine besylate is dissolved in the mixed solvent of dichloromethane and ethanol, obtains the dichloromethane / ethanol solution of levamlodipine besylate;

[0076] 2) Add n-heptane dropwise to the dichloromethane / ethanol solution of levamlodipine besylate obtained in step 1) under an ultrasonic field until crystallization occurs;

[0077] 3) Turn off the ultrasonic field, let stand, filter, wash the filter cake with dichloromethane and ethanol respectively, and dry to obtain the levamlodipine besylate crystal.

[0078] Gained levamlodipine besylate crystals use Cu-Kα rays to measure characteristic peaks in the X-ray powder diffraction pattern obtained at 2θ of 8.0°, 12.1°, 15.4°, 17.0°, 19.8°, 21.6°, 23.0° , 24.3°, 25.7°, 27.4°, 30.7° and 33.5° display, such as figure 1 shown.

[0079] Below is embodiment 2-9, and preparation method is with embodiment 1, and its concrete process parameter ...

Embodiment 1

[0085] [Formulation Example 1] Film-coated tablets of levamlodipine besylate and candesartan cilexetil

[0086] 1. Prescription

[0087] Tablet prescription:

[0088]

[0089]

[0090] Coating Solution Prescription:

[0091]

[0092] 2. Preparation process

[0093] (1) Candesartan cilexetil is passed through an 80-mesh sieve, for subsequent use;

[0094] (2) Microcrystalline cellulose, compressible starch, croscarmellose sodium, silicon dioxide and magnesium stearate were respectively baked at 60°C for 4 hours, passed through a 60-mesh sieve, and set aside;

[0095] (3) Take the above-mentioned standby candesartan cilexetil, microcrystalline cellulose, croscarmellose sodium, silicon dioxide and magnesium stearate according to the recipe quantity, and mix them uniformly by equal addition method to obtain mixed powder;

[0096] (4) Take by weighing the levamlodipine besylate crystal prepared in Example 1 of the prescription amount, mix with the mixed powder obtaine...

Embodiment 2

[0101] [Formulation Example 2] Film-coated tablets of levamlodipine besylate and candesartan cilexetil

[0102] 1. Prescription

[0103] Tablet prescription:

[0104]

[0105]

[0106] Coating Solution Prescription:

[0107]

[0108] 2. Preparation process: same as preparation example 1, the difference is that the levamlodipine besylate used is the levamlodipine besylate crystal prepared in Example 2, and step 2) is to bake at 80°C 2 hours, through 80 mesh sieves.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
hardnessaaaaaaaaaa
Login to View More

Abstract

The invention relates to a brand new drug composition containing levamlodipine besylate and candesartan cilexetil and a preparation method thereof. The composition comprises the active ingredients such as levamlodipine besylate and candesartan cilexetil and pharmaceutically acceptable auxiliaries, wherein levamlodipine besylate is levamlodipine besylate crystals; and the characteristic peak in the X-ray powder diffraction pattern obtained after measuring the crystals with a Cu-Kalpha ray is displayed at 2theta, namely 8.0 degrees, 12.1 degrees, 15.4 degrees, 17.0 degrees, 19.8 degrees, 21.6 degrees, 23.0 degrees, 24.3 degrees, 25.7 degrees, 27.4 degrees, 30.7 degrees and 33.5 degrees. The drug composition and the preparation method have the following advantages: the crystals can improve the solubility of levamlodipine besylate to some extent, thus amlodipine besylate in the drug composition is dissolved out more quickly and the drug composition has a better curative effect and good stability; and the method adopts a direct powder compression technology, has the advantages of simple technology, short production period and low production cost and is easy to realize industrial production.

Description

Technical field [0001] The invention is the field of drug preparations, involving a new drug composition and preparation method containing L -caroblitic flats and Kandetartin. Background technique [0002] Candararton ester, Chinese alias: (±) -1-[[(ring self-oxygen generation) 羰blade] oxygen generation] ethyl-2-ethyte-1- [[2 ′-(1H-tetazoleBase-5)-[1, 1′-linked phenyl] -4-base] -1H-benzene-phenazole-7-carboxylic acid, English name: Candesartan Cile Xetil, molecular formula: C 33 H 34 N 6 O 6 , Molecular quantity: 610.67, the structure is as follows: [0003] [0004] Khamartan is quickly decomposed into active metabolites in the body as active metabolitic metabolites. Kandartan is an antagonist in selective vascular tension II receptor (AT1).The blood vessel shrinkage of the vegetarian II reduces the peripheral vascular resistance.It is also believed that: Khamutan can play a certain antihypertensive effect by inhibiting adrenal secretion of aldosterone.Khandhadan does not inhi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4422
Inventor 马鹰军钟正明罗韬王小树
Owner HAINAN JINRUI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com